Do Investors Have Much Faith In Advent Technologies Holdings Inc (NASDAQ: ADN)

Advent Technologies Holdings Inc (NASDAQ:ADN) does about 1.22M shares in volume on a normal day but saw 1462543 shares change hands in Friday trading. The company now has a market cap of 8.31M USD. Its current market price is $0.11, marking a decrease of -6.87% compared to the previous close of $0.12. The 52 week high reached by this stock is $1.13 whilst the lowest price level in 52 weeks is $0.11.

Advent Technologies Holdings Inc (ADN) has a 20-day trading average at $0.1579 and the current price is -90.52% off the 52-week high compared with -3.51% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.1787 and its 200-day simple moving average is $0.3567. If we look at the stock’s price movements over the week, volatility stands at 15.93%, which decreases to 10.41% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 24.07 to suggest the stock is oversold.

The consensus objective for the share price is $0.45, suggesting that the stock has a potential upside of 75.56% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 18, 2021 when Goldman downgraded the stock to “Neutral” and issued a price target of $20.

Advent Technologies Holdings Inc (ADN) stock is down -29.35% over the week and -41.79% over the past month. Its price is -51.93% year-to-date and -83.58% over the past year.

The stock last released its quarterly earnings report for quarter ended 12/31/2022, with the company’s earnings per share (EPS) of -0.31 below consensus estimates by -0.19. The company’s next earnings report forecasts estimating quarterly EPS at 0 and -1.05 for whole year.

To reach the target analysts have set, the stock logically needs to grow 75.56 percent from here.

The company has a return on investment of -225.58% and return on equity of -133.29%. The forward price to earnings ratio is 1.07. The beta has a value of 0.17. Price to book ratio is 0.20 and price to sales ratio is 1.57.